Management of Type-2 Diabetic Patients Treated With Insulin During the Ramadan

PHASE4CompletedINTERVENTIONAL
Enrollment

245

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

October 31, 2011

Conditions
Diabetes Type 2Treatment During Ramadan
Interventions
DRUG

Insulin treatment during Ramadan

Insulin analogs will be used: Levemir and NovoMix70. The daily insulin dose will be calculated as follows: Sixty percent of the total daily dose will be used as the beginning daily dose at the first day of fasting. Sixty percent of the daily dose will be given as NovoMix70 before the Eftar (the main meal in the evening that breaks the fast). Forty percent of the amount will be given as Levemir (Early in the morning before the beginning of fasting.

DRUG

Standard of care

Standard of care during Ramadan according to physicians decision

Trial Locations (1)

Unknown

Clalit HMO, Haifa

Sponsors
All Listed Sponsors
lead

Meir Medical Center

OTHER